Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Temporary support for acute liver failure.

Pankaj Rajvanshi¹, Anne M Larson, Kris V Kowdley

¹Division of Gastroenterology and Hepatology, University of Washington School of Medicine, Seattle, Washington 98195-6174, USA.

Journal of Clinical Gastroenterology

|September 28, 2002

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A Review of Therapies for Primary Biliary Cholangitis.

Gastroenterology & hepatology·2026

Same author

The metabolic vulnerability index predicts outcomes in patients with metabolic dysfunction associated steatotic liver disease.

Nature communications·2026

Same author

Vitamin E dosing study (VEDS) in patients with metabolic dysfunction-associated steatotic liver disease with elevated aminotransferases: A multicenter, randomized, placebo-controlled trial.

Hepatology (Baltimore, Md.)·2026

Same author

New therapies for primary biliary cholangitis.

Hepatology international·2026

Same author

The ESSENCE of hope: what semaglutide's Food and Drug Administration approval means for metabolic dysfunction-associated steatohepatitis.

Hepatobiliary surgery and nutrition·2026

Same author

Baseline Alkaline Phosphatase Impacts Response Rates in Primary Biliary Cholangitis: Exploring Response to Elafibranor in ELATIVE.

Liver international : official journal of the International Association for the Study of the Liver·2026

Same journal

GLP-1 Receptor Agonists and Hepatic Encephalopathy in Cirrhosis: A Protective Signal Requiring Cancer and Nutritional Phenotyping.

Journal of clinical gastroenterology·2026

Same journal

Endoscopic Incisional Therapy for Benign Esophageal Strictures: A Systematic Review and Meta-Analysis.

Journal of clinical gastroenterology·2026

Same journal

International Consensus Statements on the Use of Topical Endoscopic Hemostatic Powders in the Treatment of Acute Gastrointestinal Bleeding.

Journal of clinical gastroenterology·2026

Same journal

Do Risk Factors for Reflux Symptoms After Peroral Endoscopic Myotomy Necessarily Increase the Occurrence of Postoperative Gastroesophageal Reflux?

Journal of clinical gastroenterology·2026

Same journal

Subgroup Stratification by Regimen, Geography, and Population Is Necessary to Validate Nitazoxanide-based Helicobacter pylori Eradication Therapy.

Journal of clinical gastroenterology·2026

Same journal

The Impact of Glucagon-Like Peptide 1 Receptor Agonists Versus Diabetes Mellitus on Endoscopic Procedures: A Case-Control Study From a Large Tertiary Care Health System.

Journal of clinical gastroenterology·2026

See all related articles

Artificial liver support systems show promise for acute liver failure (ALF) patients, but more research is needed. Current data suggest safety but are insufficient to confirm effectiveness for routine use.

Area of Science:

Hepatology
Biomedical Engineering
Regenerative Medicine

Background:

Acute liver failure (ALF) presents a critical challenge in liver disease management.
Temporary liver support aims to bridge patients to recovery or liver transplantation.
Existing treatment approaches require comprehensive review to guide clinical practice.

Purpose of the Study:

To review current treatment strategies for temporary liver support in ALF patients.
To evaluate the efficacy and safety of various liver support systems.
To identify gaps in research and suggest future directions for ALF management.

Main Methods:

Conducted a MEDLINE search (1960-1999) and manual bibliography review.
Included human studies on non-orthotopic liver transplant (OLT)-based approaches.

Related Experiment Videos

Extracted data on liver function, OLT bridging, recovery, and mortality.

Main Results:

Both cell-based and non-cell-based therapies demonstrate potential for ALF treatment.
Preliminary data indicate that these approaches are safe.
Current evidence is insufficient to establish the efficacy of these liver support systems.

Conclusions:

Routine use of artificial liver support systems is not currently recommended for ALF.
The demonstrated safety of cell- and non-cell-based devices supports further investigation.
Prospective Phase III controlled trials are warranted to evaluate efficacy in ALF patients.